News
CRBP
0.1848
+5.78%
0.0101
Why Meta Platforms Shares Are Trading Higher By 19%; Here Are 20 Stocks Moving Premarket
Benzinga · 1d ago
Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Benzinga · 01/09 18:42
Why CinCor Pharma Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket
Benzinga · 01/09 13:04
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Investor Place · 01/09 12:35
BRIEF-Corbus Pharmaceuticals Holdings - On January 4, Co Received Notice Of Delisting Or Failure To Satisfy Continued Listing Rule Or Standard From Nasdaq
Reuters · 01/06 22:02
Why Dollar General Shares Are Trading Lower By Over 8%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session
Benzinga · 12/01/2022 18:33
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 12/01/2022 17:31
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 12/01/2022 13:11
Why Okta Shares Are Trading Higher By Around 14%; Here Are 27 Stocks Moving Premarket
Benzinga · 12/01/2022 11:16
Why Leslie's Shares Are Trading Lower By Over 9%? Here Are 60 Stocks Moving In Wednesday's Mid-Day Session
Benzinga · 11/30/2022 18:00
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 11/30/2022 17:32
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 11/30/2022 13:09
Why Horizon Therapeutics Shares Are Trading Higher By Over 30%; Here Are 32 Stocks Moving Premarket
Benzinga · 11/30/2022 12:42
Why G Medical Innovations Shares Are Trading Lower By 35%; Here Are 25 Stocks Moving Premarket
Benzinga · 11/21/2022 12:45
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 11/18/2022 21:32
Why PlayAGS Shares Are Trading Lower By Over 15%; Here Are 33 Stocks Moving Premarket
Benzinga · 11/15/2022 12:49
Corbus Presents Latest Preclinical Data For CRB-601 At Society For Immunotherapy Of Cancer (SITC) 37th Annual Meeting
Benzinga · 11/10/2022 14:08
Why Array Technologies Shares Are Trading Sharply Higher; Here Are 28 Stocks Moving Premarket
Benzinga · 11/09/2022 11:16
BRIEF-Corbus Pharmaceuticals Reports Third Quarter Results
Reuters · 11/08/2022 15:38
Corbus Pharmaceuticals GAAP EPS of -$0.07 misses by $0.01
Seekingalpha · 11/08/2022 13:44
More
Webull provides a variety of real-time CRBP stock news. You can receive the latest news about Corbus Pharmaceu through multiple platforms. This information may help you make smarter investment decisions.
About CRBP
Corbus Pharmaceuticals Holdings, Inc. is focused on the development of immune modulators that have application in disease states spanning from immuno-oncology to fibrosis. The Company’s pipeline includes anti-integrin monoclonal antibodies that block activation of TGFβ and small molecules that activate or inhibit the endocannabinoid system. The Company pipeline includes Anti-integrin monoclonal antibodies (mAbs), Cannabinoid receptor type 1 (CB1) and Lenabasum. The mAbs is for the treatment of cancer and fibrosis that inhibit the activation of Transforming growth factor β (TGFβ). Its CRB-601 is an anti-αvβ8 mAb being developed as a potential treatment for solid tumors in combination with existing therapies, including checkpoint inhibitors. Cannabinoid receptor type 1 (CB1) is an inverse agonist designed to treat obesity and related metabolic diseases. Lenabasum is a novel, synthetic, oral molecule that selectively activates cannabinoid receptor type 2 (CB2).